Vectors Research Management’s Idexx Laboratories IDXX Stock Holding History

Vectors Research Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-96	Closed	-$34K	–	290
2022 Q2	$34K	Hold	96	–	–	0.01%	250
2022 Q1	$53K	Hold	96	–	–	0.01%	220
2021 Q4	$63K	Hold	96	–	–	0.01%	239
2021 Q3	$60K	Hold	96	–	–	0.01%	222
2021 Q2	$61K	Hold	96	–	–	0.02%	220
2021 Q1	$47K	Hold	96	–	–	0.01%	226
2020 Q4	$48K	Hold	96	–	–	0.01%	203
2020 Q3	$38K	Hold	96	–	–	0.01%	190
2020 Q2	$32K	Hold	96	–	–	0.01%	201
2020 Q1	$23K	Hold	96	–	–	0.01%	215
2019 Q4	$25K	Buy	+96	New	+$25.3K	0.01%	244

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Vectors Research Management's IDXX Position: Q3 2022 in Review

Vectors Research Management sold out of Idexx Laboratories (IDXX) in Q3 2022, closing a stake of 96 shares — an estimated $34K sold.

Vectors Research Management first reported a position in IDXX in Q4 2019 and held it in 11 quarters. The position peaked at $63K in Q4 2021. 922 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

Vectors Research Management reported no remaining Idexx Laboratories position as of Q3 2022 after selling out during the quarter.
Vectors Research Management sold 96 Idexx Laboratories shares in Q3 2022, an estimated $34K.
Vectors Research Management first reported a position in Idexx Laboratories in Q4 2019 and held it in 11 quarters.
Vectors Research Management's Idexx Laboratories position peaked at $63K in Q4 2021.
922 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on Vectors Research Management's 13F filing for Q3 2022, filed 8 Nov 2022.